Status:
COMPLETED
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
Lead Sponsor:
Mayo Clinic
Conditions:
Clostridioides Difficile Infection
Eligibility:
All Genders
18+ years
Brief Summary
This research is being done to study the ability of C. difficile to colonize the colonic mucosa of individuals with no prior history of C. difficile infection.
Detailed Description
The ability of C. difficile to colonize the mucosa of the colon will be studied in healthy individuals with no history of C. difficile infection who are undergoing colonoscopy for colon cancer/polyp s...
Eligibility Criteria
Inclusion
- Adults aged 18 and over
- No history of C. difficile infection
- Undergoing clinically indicated colonoscopy for colon cancer screening or colon polyp surveillance purposes in the absence of active GI symptoms.
Exclusion
- Known active pregnancy
- Other known active gastrointestinal infectious process
- Inflammatory gastrointestinal conditions (microscopic colitis, inflammatory bowel disease, Celiac disease)
- Vulnerable adults
- Any other disease(s), condition(s) or habit(s) that would interfere with completion of study, or in the judgment of the investigator would potentially interfere with compliance to this study or would adversely affect study outcomes
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 23 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04668014
Start Date
September 1 2019
End Date
December 23 2020
Last Update
July 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905